Dong Sung Bio Pharm.Co.,Ltd. (KRX:002210)
973.00
-1,807.00 (-65.00%)
At close: Jun 24, 2025
KRX:002210 Revenue
In the year 2011, Dong Sung Bio Pharm.Co.,Ltd. had annual revenue of 78.44B KRW with 9.06% growth. Dong Sung Bio Pharm.Co.,Ltd. had revenue of 18.57B in the quarter ending June 30, 2013, a decrease of -0.97%.
Revenue
78.44B
Revenue Growth
+13.99%
P/S Ratio
0.30
Revenue / Employee
270.49M
Employees
290
Market Cap
23.24B
Revenue Chart
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Aprogen Biologics | 74.91B |
| MYUNGMOON Pharm co.,Ltd | 193.64B |
| Yuyu Pharma | 139.51B |
| Enzychem Lifesciences | 72.17B |
| Kukje Pharma | 173.80B |
| CKD Bio | 159.93B |
| Ildong Holdings | 620.44B |
| Kyongbo Pharmaceutical | 252.20B |